MYO1F and hyperlipidemia: Subsequent analysis of the diagnostic value of these genes in obstructive CAD further confirmed that NCF2, MYO1F, S1PR4, and FCN1 together with risk factors, gender, and hyperlipidemia, could improve the diagnostic accuracy of distinguishing obstructive CAD from free of obstructive CAD.